Zhuhai Rundu Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Zhuhai Rundu Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 35 active records with this name as holder; 43 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
49 acceptance records as first applicant, grouped into 31 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Losartan Potassium Tablets 3 records · Latest accepted 2026/10/10
Generic · 3
Diclofenac Sodium Sustained Release Tablets 3 records · Latest accepted 2026/09/04
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601687 | Supplement | 2026/09/04 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2500745 | Generic | 2025/02/15 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2500744 | Generic | 2025/02/15 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 4 records · Latest accepted 2026/07/01
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601240 | Supplement | 2026/07/01 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601239 | Supplement | 2026/07/01 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402721 | Generic | 2024/08/21 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402720 | Generic | 2024/08/21 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Betahistine Mesilate Tablets 1 records · Latest accepted 2026/05/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601090 | Generic | 2026/05/13 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Lansoprazole Enteric Capsules 1 records · Latest accepted 2026/04/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600971 | Generic | 2026/04/27 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Amiodarone Hydrochloride Tablets 1 records · Latest accepted 2026/04/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600788 | Generic | 2026/04/08 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Furosemide Tablets 1 records · Latest accepted 2025/11/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503971 | Generic | 2025/11/15 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Mosapride Citrate Tablets 1 records · Latest accepted 2025/11/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503912 | Generic | 2025/11/11 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Ibuprofen Tablets 2 records · Latest accepted 2025/07/22
Generic · 2
Isosorbide Mononitrate Sustained-release Capsules 2 records · Latest accepted 2025/07/16
Supplement · 2
Gliclazide Tablets 1 records · Latest accepted 2025/04/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501529 | Generic | 2025/04/23 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Isosorbide Dinitrate Injection 2 records · Latest accepted 2025/04/17
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501462 | Generic | 2025/04/17 | Zhuhai Rundu Pharmaceutical Co., Ltd.; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
| CYHS2500234 | Generic | 2025/01/10 | Zhuhai Rundu Pharmaceutical Co., Ltd.; HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | CDE ↗ |
Candesartan Cilexetil Tablets 2 records · Latest accepted 2025/03/15
Generic · 2
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2025/03/07
Generic · 2
Hydroxychloroquine Sulfate Tablets 1 records · Latest accepted 2024/12/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404397 | Generic | 2024/12/18 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Valacyclovir Hydrochloride Tablets 1 records · Latest accepted 2024/11/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450554 | Supplement | 2024/11/05 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Regadenoson Injection 1 records · Latest accepted 2024/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400112 | Generic | 2024/06/14 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
IsosorbideMononitrate Tablets 2 records · Latest accepted 2024/05/11
Generic · 2
盐酸去甲乌药碱注射液 · No verified English name 1 records · Latest accepted 2024/03/02
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2400019 | New drug | 2024/03/02 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Valsartan and Amlodipine Tablets(I) 1 records · Latest accepted 2024/01/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400118 | Generic | 2024/01/10 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2024/01/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400029 | Generic | 2024/01/04 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil and Hydrochlorothiazide Tablets 2 records · Latest accepted 2023/11/03
Generic · 2
Moxifloxacin Hydrochloride Tablets 1 records · Latest accepted 2023/08/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302288 | Generic | 2023/08/29 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Irbesartan Tablets 1 records · Latest accepted 2023/08/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301765 | Supplement | 2023/08/02 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Levobupivacaine Hydrochloride Injection 3 records · Latest accepted 2023/04/12
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350332 | Supplement | 2023/04/12 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2150516 | Supplement | 2021/03/22 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2150515 | Supplement | 2021/03/22 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Rabeprazole Sodium Enteric-coated Tablets 2 records · Latest accepted 2023/02/04
Generic · 2
Valsartan and Hydrochlorothiazide Tablets 1 records · Latest accepted 2023/01/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300141 | Generic | 2023/01/14 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
厄贝沙坦氢氯噻嗪片 · No verified English name 1 records · Latest accepted 2022/09/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201690 | Supplement | 2022/09/20 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Valsartan Film-Coated Tablets 2 records · Latest accepted 2022/08/22
Supplement · 1Generic · 1
Voriconazole for Oral Suspension 1 records · Latest accepted 2022/02/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200293 | Generic | 2022/02/14 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil Tablets 1 records · Latest accepted 2021/06/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101287 | Generic | 2021/06/11 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 3 applications
- 2026/10/10Accepted
Losartan Potassium Tablets
CYHS2602486
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/10/10Accepted
Losartan Potassium Tablets
CYHS2602485
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/04Accepted
Diclofenac Sodium Sustained Release Tablets
CYHB2601687
Fact date: 2026/09/04 · Date added to this site: 2026/10/22
View source ↗
Under review
10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Losartan Potassium Tablets | CYHS2602486 | Generic | 2026/10/10 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Losartan Potassium Tablets | CYHS2602485 | Generic | 2026/10/10 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | CYHB2601687 | Supplement | 2026/09/04 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Betahistine Mesilate Tablets | CYHS2601090 | Generic | 2026/05/13 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Lansoprazole Enteric Capsules | CYHS2600971 | Generic | 2026/04/27 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Amiodarone Hydrochloride Tablets | CYHS2600788 | Generic | 2026/04/08 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Furosemide Tablets | CYHS2503971 | Generic | 2025/11/15 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Mosapride Citrate Tablets | CYHS2503912 | Generic | 2025/11/11 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ibuprofen Tablets | CYHS2502645 | Generic | 2025/07/22 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Gliclazide Tablets | CYHS2501529 | Generic | 2025/04/23 | Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
35 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Isosorbide Dinitrate Injection | Zhuhai Rundu Pharmaceutical Co., Ltd. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20265264 | 2026/07/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20265138 | 2026/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20265137 | 2026/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isosorbide Dinitrate Injection | Zhuhai Rundu Pharmaceutical Co., Ltd. | HARBIN MEDISAN PHARMACEUTICAL CO.,LTD. | 国药准字H20264816 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20264430 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20264471 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ibuprofen Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20263388 | 2026/02/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Candesartan Cilexetil Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20263316 | 2026/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20263184 | 2026/01/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20263183 | 2026/01/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan and Amlodipine Tablets(I) | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20255570 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valacyclovir Hydrochloride Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20258207 | 2025/09/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| IsosorbideMononitrate Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20255160 | 2025/08/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20254689 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil and Amlodipine Besylate Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20254170 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| IsosorbideMononitrate Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20254045 | 2025/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Irbesartan Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字 H20247271 | 2024/11/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20244680 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan and Hydrochlorothiazide Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20244151 | 2024/06/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levobupivacaine Hydrochloride Injection | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20070023 | 2024/02/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20243284 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voriconazole for Oral Suspension | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20243108 | 2024/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rabeprazole Sodium Enteric-coated Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20234543 | 2023/11/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan Film-Coated Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20237080 | 2023/07/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rabeprazole Sodium Enteric-coated Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20233776 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20223947 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan Film-Coated Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20223378 | 2022/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levobupivacaine Hydrochloride Injection | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20227035 | 2022/03/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levobupivacaine Hydrochloride Injection | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20050403 | 2022/03/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 盐酸伊托必利片 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20223071 | 2022/02/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil Tablets | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20213515 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 吲达帕胺胶囊 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20040548 | 2021/05/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 厄贝沙坦氢氯噻嗪片 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20203678 | 2020/12/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isosorbide Mononitrate Sustained-release Capsules | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20073914 | 2020/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Isosorbide Mononitrate Sustained-release Capsules | Zhuhai Rundu Pharmaceutical Co., Ltd. | Zhuhai Rundu Pharmaceutical Co., Ltd. | 国药准字H20073915 | 2020/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
43 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 双氯芬酸二乙胺 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20250001115 | I | 2025/11/17 | CDE ↗ |
| 富马酸伏诺拉生 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20250000526 | A | 2026/11/04 | CDE ↗ |
| 苯磺酸左氨氯地平 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240001262 | A | 2026/08/31 | CDE ↗ |
| 枸橼酸莫沙必利 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240001424 | A | 2026/10/12 | CDE ↗ |
| 碳酸镧 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240001423 | A | 2026/07/20 | CDE ↗ |
| 氯沙坦钾 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240001335 | A | 2026/04/29 | CDE ↗ |
| 苯磺酸氨氯地平 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240001261 | A | 2026/07/21 | CDE ↗ |
| 替米沙坦 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240001072 | A | 2026/05/15 | CDE ↗ |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240000743 | A | 2026/01/16 | CDE ↗ |
| 硝酸异山梨酯 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240000478 | A | 2026/11/13 | CDE ↗ |
| 氢氯噻嗪 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240000290 | A | 2026/11/13 | CDE ↗ |
| 硫酸氨基葡萄糖氯化钠复盐 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20230001261 | A | 2025/08/11 | CDE ↗ |
| 盐酸去甲乌药碱 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20240000059 | A | 2026/04/20 | CDE ↗ |
| 硫酸羟氯喹 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20220000403 | A | 2024/11/01 | CDE ↗ |
| 美阿沙坦钾 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20220000492 | A | 2025/05/17 | CDE ↗ |
| 瑞加诺生 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20210000559 | A | 2024/03/27 | CDE ↗ |
| 单硝酸异山梨酯 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20220000036 | A | 2026/03/11 | CDE ↗ |
| 艾司奥美拉唑镁 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20210000622 | A | 2023/11/24 | CDE ↗ |
| 阿齐沙坦 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20210000299 | A | 2023/06/28 | CDE ↗ |
| 布洛芬 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20210000195 | A | 2026/06/18 | CDE ↗ |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20200001073 | A | 2024/11/30 | CDE ↗ |
| 羧胺三唑 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20200001181 | I | 2021/01/20 | CDE ↗ |
| 右雷佐生 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20200000986 | A | 2024/08/23 | CDE ↗ |
| 双氯芬酸钠 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190021545 | A | 2026/03/31 | CDE ↗ |
| 替米沙坦 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20209990018 | A | 2026/09/01 | CDE ↗ |
| 缬沙坦 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190009810 | A | 2024/07/27 | CDE ↗ |
| 厄贝沙坦 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190009727 | A | 2025/01/17 | CDE ↗ |
| 盐酸伊托必利 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190009712 | A | 2026/02/07 | CDE ↗ |
| 泛酸钠 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190009707 | A | 2024/11/05 | CDE ↗ |
| 雷贝拉唑钠 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190009605 | A | 2025/11/14 | CDE ↗ |
| 兰索拉唑 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190009470 | A | 2024/11/13 | CDE ↗ |
| 盐酸伐昔洛韦 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190007854 | A | 2024/09/24 | CDE ↗ |
| 磷酸哌喹 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190006781 | A | — | CDE ↗ |
| 尼麦角林 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190006587 | A | 2026/06/17 | CDE ↗ |
| 盐酸左布比卡因 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190004099 | A | 2024/11/23 | CDE ↗ |
| 伏立康唑 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190004098 | A | 2024/11/05 | CDE ↗ |
| 甲磺酸左氧氟沙星 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20190002952 | A | 2026/06/23 | CDE ↗ |
| 硫酸奎尼丁 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20170001464 | A | 2026/07/28 | CDE ↗ |
| 达沙替尼 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20170001371 | A | 2024/10/24 | CDE ↗ |
| 盐酸度洛西汀 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20170000807 | A | 2024/03/22 | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20170000798 | A | 2025/07/19 | CDE ↗ |
| 奥美沙坦酯 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20170000394 | A | 2025/01/17 | CDE ↗ |
| 坎地沙坦酯 · No verified English name | Zhuhai Rundu Pharmaceutical Co., Ltd. | Y20170000131 | A | 2025/09/12 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
11 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Sildenafil Citrate Oral Disintegrating Tablets | CYHS2602376 | Generic | 2026/09/21 | Guangzhou Hu Rui Pharmaceuticals Technology Development Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | CYHS2501538 | Generic | 2025/04/24 | Guangzhou Hu Rui Pharmaceuticals Technology Development Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Bilastine Orally disintegrating Tablets | CYHS2500717 | Generic | 2025/02/13 | Guangdong Ren Xiang Pharma Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Levocarnitine Injection | CYHS2500687 | Generic | 2025/02/10 | Guangzhou Ze Sheng Pharma Technology Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Levocarnitine Injection | CYHS2500686 | Generic | 2025/02/10 | Guangzhou Ze Sheng Pharma Technology Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| 维生素B?注射液 · No verified English name | CYHS2404604 | Generic | 2024/12/28 | Guangdong Jun Kang Pharma Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Bepotastine Besilate Orally Disintegrating Tablets | CYHS2403441 | Generic | 2024/10/13 | Guangdong Jiang Zheng Pharma Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Finasteride Tablets | CYHS2403275 | Generic | 2024/09/27 | Heng Chang (Guangzhou) Xin Yao Research Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| 非那雄胺分散片 · No verified English name | CYHB2450370 | Supplement | 2024/07/11 | Heng Chang (Guangzhou) Xin Yao Research Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Pamidronate Disodium Injection | CYHS2401043 | Generic | 2024/04/09 | Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
| Glucosamine Sulfate Capsules | CYHS2300809 | Generic | 2023/03/16 | Guangzhou Hu Rui Pharmaceuticals Technology Development Co., Ltd. romanized; Zhuhai Rundu Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.